Xenon Pharmaceuticals  logo
Xenon Pharmaceuticals XENE
$ 40.2 2.19%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Xenon Pharmaceuticals Balance Sheet 2011-2024 | XENE

Annual Balance Sheet Xenon Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-138 M -46.8 M -167 M - -9.22 M -52.7 M -13.7 M -17.1 M -58.7 M -72 M -38 M -58.5 M -

Long Term Debt

9.6 M 9.95 M 7.65 M - 10.9 M 15 M 6.1 M - - - - 1.66 M -

Long Term Debt Current

1.3 M 488 K 605 K 265 K 168 K - 700 K - - - - - -

Total Non Current Liabilities

- - - - 12.3 M 15 M 6.1 M 70 K 133 K 353 K 12.2 M 31.5 M -

Total Current Liabilities

27.3 M 22.7 M 14.3 M 14.8 M 43.4 M 4.12 M 4.08 M 3.52 M 2.78 M 14.3 M - - -

Total Liabilities

36.9 M 32.6 M 22 M 17.8 M 55.7 M 19.1 M 10.2 M 3.59 M 2.92 M 14.6 M 30.4 M 50.7 M -

Deferred Revenue

- - - - 29.7 M - - - 157 K 11.6 M 15.9 M 17 M -

Retained Earnings

-665 M -483 M -357 M -278 M -250 M -208 M -173 M -143 M -120 M -104 M -117 M -129 M -

Total Assets

965 M 754 M 572 M 189 M 148 M 122 M 46.1 M 67.5 M 63.9 M 87.4 M 54.5 M 63.3 M -

Cash and Cash Equivalents

149 M 57.2 M 176 M 45 M 24.8 M 67.8 M 20.5 M 17.1 M 58.7 M 72 M 38 M 60.2 M -

Book Value

928 M 721 M 550 M 171 M 92 M 103 M 35.9 M 63.9 M 61 M 72.8 M 24.1 M 12.6 M -

Total Shareholders Equity

928 M 721 M 550 M 171 M 92 M 103 M 35.9 M 63.9 M 61 M 72.8 M -78.4 M -89.9 M -

All numbers in USD currency

Quarterly Balance Sheet Xenon Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

8.4 M 8.68 M 9.1 M 9.6 M 9.76 M 10.3 M 10.4 M 9.95 M 7.16 M 7.85 M 8.22 M 7.65 M 2.56 M 2.75 M 2.9 M 3.05 M 3.05 M 3.05 M 3.05 M 10.9 M 10.9 M 10.9 M 10.9 M 15 M 15 M 15 M 15 M 6.1 M 6.1 M 6.1 M 6.1 M - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

38.1 M 40 M 31.3 M 36.9 M 34.5 M 38.4 M 32.9 M 32.6 M 22.7 M 21.6 M 16.2 M 22 M 15.4 M 17.7 M 14.4 M 17.8 M 17.8 M 17.8 M 17.8 M 55.7 M 55.7 M 55.7 M 55.7 M 19.1 M 19.1 M 19.1 M 19.1 M 10.2 M 10.2 M 10.2 M 10.2 M 3.59 M 3.59 M 3.59 M 3.59 M 2.92 M 2.92 M 2.92 M 2.92 M 14.6 M 14.6 M 14.6 M 14.6 M 30.4 M 30.4 M - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - 2.2 M 3.02 M 3.64 M 3.64 M 3.64 M 3.64 M 3.64 M 29.7 M 29.7 M 29.7 M 29.7 M - - - - - - - - - - - - 157 K 157 K 157 K 157 K 11.6 M 11.6 M 11.6 M 11.6 M 15.9 M 15.9 M - - - - - - - - - -

Retained Earnings

-834 M -771 M -713 M -665 M -620 M -572 M -524 M -483 M -445 M -408 M -377 M -357 M -332 M -316 M -294 M -278 M -278 M -278 M -278 M -250 M -250 M -250 M -250 M -208 M -208 M -208 M -208 M -173 M -173 M -173 M -173 M -143 M -143 M -143 M -143 M -120 M -120 M -120 M -120 M -104 M -104 M -104 M -104 M -117 M -117 M - - - - - - - - - -

Total Assets

836 M 884 M 919 M 965 M 671 M 685 M 720 M 754 M 776 M 807 M 558 M 572 M 264 M 275 M 291 M 189 M 189 M 189 M 189 M 148 M 148 M 148 M 148 M 122 M 122 M 122 M 122 M 46.1 M 46.1 M 46.1 M 46.1 M 67.5 M 67.5 M 67.5 M 67.5 M 63.9 M 63.9 M 63.9 M 63.9 M 87.4 M 87.4 M 87.4 M 87.4 M 54.5 M 54.5 M - - - - - - - - - -

Cash and Cash Equivalents

87.6 M 137 M 58.9 M 149 M 99.6 M 64.6 M 69.5 M 57.2 M 103 M 370 M 117 M 176 M 87.8 M 82.9 M 88 M 45 M 45 M 45 M 45 M 24.8 M 24.8 M 24.8 M 24.8 M 67.8 M 67.8 M 67.8 M 67.8 M 20.5 M 20.5 M 20.5 M 20.5 M 17.1 M 17.1 M 17.1 M 17.1 M 58.7 M 58.7 M 58.7 M 58.7 M 72 M 72 M 72 M 72 M 38 M 38 M - - 60.2 M - - - 13.9 M - - -

Book Value

798 M 844 M 888 M 928 M 637 M 646 M 687 M 721 M 753 M 786 M 542 M 550 M 249 M 257 M 276 M 171 M 171 M 171 M 171 M 92 M 92 M 92 M 92 M 103 M 103 M 103 M 103 M 35.9 M 35.9 M 35.9 M 35.9 M 63.9 M 63.9 M 63.9 M 63.9 M 61 M 61 M 61 M 61 M 72.8 M 72.8 M 72.8 M 72.8 M 24.1 M 24.1 M - - - - - - - - - -

Total Shareholders Equity

798 M 844 M 888 M 928 M 637 M 646 M 687 M 721 M 753 M 786 M 542 M 550 M 249 M 257 M 276 M 171 M 171 M 171 M 171 M 92 M 92 M 92 M 92 M 103 M 103 M 103 M 103 M 35.9 M 35.9 M 35.9 M 35.9 M 63.9 M 63.9 M 63.9 M 63.9 M 61 M 61 M 61 M 61 M 72.8 M 72.8 M 72.8 M 72.8 M -78.4 M -78.4 M - - -89.9 M - - - -86.3 M - - -

All numbers in USD currency